Immunoreceptor tyrosine-based inhibitory motif

The Immunoreceptor Tyrosine-based Inhibitory Motif (ITIM) is a conserved sequence motif found in the cytoplasmic tails of various immune receptors. ITIMs play a crucial role in the regulation of immune responses by mediating inhibitory signals that counteract activation signals, thus maintaining immune homeostasis and preventing autoimmunity.

Structure

The ITIM is characterized by the consensus sequence Isoleucine/Valine/Leucine-X-Tyrosine-X-X-Leucine/Valine (I/V/L-X-Y-X-X-L/V), where "X" represents any amino acid. This motif is typically located in the cytoplasmic domain of receptors and is phosphorylated on the tyrosine residue upon receptor engagement.

Function

ITIMs are primarily involved in the negative regulation of cell signaling pathways. Upon phosphorylation, the tyrosine residue within the ITIM serves as a docking site for SH2 domain-containing phosphatases, such as SHP-1 and SHP-2, or the inositol phosphatase SHIP. These phosphatases dephosphorylate key signaling molecules, thereby attenuating the activation signals and leading to an inhibitory effect on the immune cell.

Mechanism of Action

When an immune receptor containing an ITIM is engaged by its ligand, the ITIM is phosphorylated by Src family kinases. This phosphorylation event creates a binding site for SH2 domain-containing phosphatases. The recruitment of these phosphatases to the ITIM-bearing receptor leads to the dephosphorylation of downstream signaling molecules, such as Syk and ZAP-70, which are critical for the propagation of activation signals. As a result, the activation of immune cells is dampened, preventing excessive immune responses.

Role in Immune Regulation

ITIM-containing receptors are expressed on various immune cells, including B cells, T cells, natural killer cells, and myeloid cells. These receptors are crucial for maintaining immune tolerance and preventing autoimmune diseases. For example, the FcγRIIB receptor on B cells contains an ITIM and plays a key role in the negative regulation of B cell activation and antibody production.

Clinical Significance

Dysregulation of ITIM-mediated signaling can lead to immune-related disorders. For instance, mutations or deficiencies in ITIM-containing receptors or their associated phosphatases can result in autoimmune diseases or immunodeficiencies. Understanding the mechanisms of ITIM function is therefore critical for developing therapeutic strategies to modulate immune responses in various diseases.

Examples of ITIM-containing Receptors

• FcγRIIB
• KIR (Killer-cell Immunoglobulin-like Receptors)
• LAIR-1 (Leukocyte-associated Immunoglobulin-like Receptor 1)
• PD-1 (Programmed cell death protein 1)

Research and Therapeutic Implications

Research into ITIMs and their associated signaling pathways is ongoing, with the aim of developing novel therapies for autoimmune diseases, cancer, and other conditions where immune regulation is disrupted. Targeting ITIM pathways may offer opportunities to enhance or suppress immune responses as needed for therapeutic benefit.

See Also

• Immunoreceptor Tyrosine-based Activation Motif (ITAM)
• Immune checkpoint
• Signal transduction